Interleukin-1 system in CNS stress: Seizures, fever, and neurotrauma

Annals of the New York Academy of Sciences

Volumn 1113, Issue , 2007, Pages 173-177

  Bartfai, Tamas ^a   Sanchez Alavez, Manuel ^a   Andell Jonsson, Siv ^b   Schultzberg, Marianne ^b   Vezzani, Annamaria ^c   Danielsson, Erik ^d   Conti, Bruno ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b STOCKHOLM UNIVERSITY   (Sweden)

^c MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^d Malmö Almänna Sjukhus   (Sweden)

Author keywords

Anticonvulsant; Fever; Interleukin 1 receptor antagonist; Interleukin 1 ; Neurotrauma; Seizure

Indexed keywords

ANTICONVULSIVE AGENT; ANTIPYRETIC AGENT; CYCLOOXYGENASE 2; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1BETA; INTERLEUKIN 6; NEUROTRANSMITTER;

AUTOREGULATION; BRAIN INFECTION; CENTRAL NERVOUS SYSTEM; CEREBROSPINAL FLUID; CONCENTRATION (PARAMETERS); CONFERENCE PAPER; CORRELATION FUNCTION; ENCEPHALITIS; FEVER; NERVE CELL; NERVOUS SYSTEM INJURY; NEUROLOGY; NONHUMAN; OUTCOME ASSESSMENT; PROTEIN BINDING; SEIZURE; STRESS; TRAUMATIC BRAIN INJURY;

EID: 35548985825     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1391.022     Document Type: Conference Paper

References (16)

1. XIA, Y. et al. 1999. IL-1β and IL-6 excite neurons and suppress nicotinic and noradrenergic neurotransmission in guinea pig enteric nervous system. J. Clin. Invest. 103: 1309-1316.
2. VIVIANI, B. et al. 2003. Interleukin-1β enhances NMDA receptor-mediated intracellular calcium increase through activation of the Src family of kinases. J. Neurosci. 23: 8692-8700.
3. SANCHEZ-ALAVEZ, M. et al. 2006. Ceramide mediates the rapid phase of febrile response to IL-1β. Proc. Natl. Acad. Sci. USA 103: 2904-2908.
4. KATSUKI, H. et al. 1990. Interleukin-1 beta inhibits long-term potentiation in the CA3 region of mouse hippocampal slices. Eur. J. Pharmacol. 181: 323-326.
5. VEZZANI, A. et al. 2000. Powerful anticonvulsant action of IL-1 receptor antagonist on intracerebral injection and astrocytic overexpression in mice. Proc. Natl. Acad. Sci. USA 97: 11534-11539.
6. DANTZER, R. et al. 1998. Cytokines and sickness behavior. Ann. N. Y. Acad. Sci. 840: 586-590.
7. LUHESHI, G.N. et al. 1999. Leptin actions on food intake and body temperature are mediated by IL-1. Proc. Natl. Acad. Sci. USA 96: 7047-7052.
8. ALHEIM, K. & T. BARTFAI. 1998. The interleukin-1 system: receptors, ligands, and ICE in the brain and their involvement in the fever response. Ann. N. Y. Acad. Sci. 840: 51-58.
9. NICKLIN, M.J. et al. 2000. Arterial inflammation in mice lacking the interleukin 1 receptor antagonist gene. J. Exp. Med. 191: 303-312.
10. LUNDKVIST, J. et al. 1999. Acute-phase responses in transgenic mice with CNS overexpression of IL-1 receptor antagonist. Am. J. Physiol. 276: R644.
11. TSAI, T.H. et al. 2003. Gene treatment of cerebral stroke by rAAV vector delivering IL-1ra in a rat model. Neuroreport 14: 803-807.
12. MULCAHY, N.J. et al. 2003. Delayed administration of interleukin-1 receptor antagonist protects against transient cerebral ischaemia in the rat. Br. J. Pharmacol. 140: 471-476.
13. EMSLEY, H.C. et al. 2005. A randomised phase II study of interleukin-1 receptor antagonist in acute stroke patients. J. Neurol. Neurosurg. Psychiatry 76: 1366-1372.
14. TEHRANIAN, R. et al. 2002. Improved recovery and delayed cytokine induction after closed head injury in mice with central overexpression of the secreted isoform of the interleukin-1 receptor antagonist. J. Neurotrauma 19: 939-951.
15. OPRICA, M. et al. 2005. Transgenic overexpression of interleukin-1 receptor antagonist in the CNS influences behaviour, serum corticosterone and brain monoamines. Brain Behav. Immun. 19: 223-234.
16. SHAVIT, Y. et al. 2005. Interleukin-1 antagonizes morphine analgesia and underlies morphine tolerance. Pain 115: 50-59.